| Name | Title | Contact Details |
|---|
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Texas American Title Company is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about Texas American Title Company, please visit www.texasamerican.com
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products and providing them to people in more than 100 countries.
Optics Institute of Southern California is a Tustin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
COMFORT CARE MEDICARE INC is a Cedar Falls, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.